Tranexamic Acid During Prehospital Transport
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Tranexamic Acid During Prehospital Transport
-
ナレーター：
-
著者：
概要
Are you ready to dive into the latest evidence on trauma care? In our fourth episode of "From Science to the Scene," we break down the STAAMP trial to see if pre-hospital administration of tranexamic acid (TXA) truly improves survival for patients at risk for hemorrhage. While the study found that pre-hospital TXA did not significantly lower the overall 30-day mortality rate, the data revealed critical benefits for specific groups. The results indicate that the Clinician can significantly impact outcomes by providing the medication within one hour of injury or to patients in severe shock. Furthermore, the study confirmed that pre-hospital TXA is safe and does not increase the risk of adverse events like blood clots or seizures. We invite you to explore how these findings might influence your practice or educational curriculum by listening to the full episode and reviewing the research today.
Read the full research paper here: https://jamanetwork.com/journals/jamasurgery/fullarticle/2771225
#NREMT #EMS #EMT #paramedic #research #TXA #medical #healthcare #medicine #study #researcher #ambulance #emergency